Cancers, Vol. 15, Pages 5801: Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine Model

Conclusions: Multisite intratumoral therapy in tandem with systemic treatment holds promise for reducing the tumor size and enhancing the overall survival in LAPC.

Source: Cancers - December 11, 2023 Category: Cancer & Oncology Authors: Janette Lazarovits Ron Epelbaum Jesse Lachter Yaron Amikam Jacob Ben Arie Tags: Article Source Type: research